Last week, Sarepta Therapeutics said it would fire hundreds of employees, confirmed a third recent patient death in another disease, and started a showdown with the FDA over the agency’s attempt to pull its Duchenne gene therapy from the market.
I spoke with our reporters who are working on the story, Jared Whitlock and Lei Lei Wu, about the last few chaotic days, where the story goes from here, and what we’re trying to find out from the company, from patients, from investors and from regulators.
You can watch the episode on our YouTube stream, or find us on Spotify and Apple podcasts by searching "Endpoints News."
And if you work at Sarepta or just left, or if you’re a patient or physician, we want to hear from you. This episode includes a segment on how to reach us on the encrypted messaging app, Signal. You can contact Jared at jaredwhitlock.73 and Lei Lei at leileiwu.24 — and we will protect your privacy and confidentiality if you reach out.)
Thanks for watching and listening! — Drew
↧